Global Adult Vaccine Market Report By Type (Preventive Vaccine And Therapeutic Vaccine), By Disease (Influenza, Meningococcal, Cervical Cancer, Zoster Shingles, Pneumococcal, Hepatitis, Measles, Mumps, Rubella And Varicella (MMRV), And Diphtheria, Tetanus, Pertussis (DTP)) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11210086
January 2020
Report Formats:

Rising prevalence of infectious diseases in the adult population is a prominent factor driving the market growth. Increasing investment in R&D by governmental bodies for the development of novel drugs and vaccine is further boosting the market growth. Also, rising awareness among the population regarding the advantages of vaccination is further pushing the market growth uphill. Favorable governmental support by arranging free campaign for vaccination is again fueling the market growth.

The latest report by Value Market Research expects the Global Adult Vaccine Market was valued at USD 15 billion in 2017 and is likely to reach USD 22.5 billion by 2024 with CAGR of 5%.
 
THERAPEUTIC VACCINES DOMINATED THE SEGMENT
In 2017, therapeutic vaccine led the segment and has accounted for X.X% of the total market share owing to its ability to induce an immune response and treat virus-infected cells is driving the market growth.
 
Influenza emerged as the leading disease
Influenza dominated the disease segment and has accounted for over 15% of the total market share.  Rising cases of acute respiratory infection, asthma, pneumonia, sinus problems, and other illness majorly caused by influenza are majorly driving the market growth.
 
NORTH AMERICA DOMINATED THE REGIONAL MARKET
Geographically, North America led the market and has accounted for X.X% of the total market share. The North American market is majorly driven owing to improved research infrastructure coupled with increased expenditure on healthcare. Rising initiates by the government for promoting vaccination is further fueling the regional market growth.
 
KEY PLAYERS OF THE MARKET
AstraZeneca Plc., Bharat Biotech, CSL Limited, Dynavax Technologies Corporation, GlaxoSmithKline, ImmunoBiology Ltd., Johnson & Johnson, Medimmune, Merck and Co., Novartis, Pfizer, Sanofi Pasteur and Serum Institute of India are the key players of the Adult Vaccine market.

As per this study the Global Adult Vaccine Market was valued at USD XX BN (by revenue) in 2019 and is anticipated to reach USD XX.X BN by 2026 with a CAGR of X.X%.
 
Vaccine refers to a biological preparation that includes inactive antigen used to create an immune response. Adult vaccines impart immunity in the adult population from various fatal infectious diseases. Vaccination in adults varies depending upon the age, lifestyle, and health condition of the individual. Adult vaccines are used to provide immunity against diphtheria, influenza, hepatitis A & B, human papillomavirus (HPV), mumps, measles, rubella And varicella {MMRV}, and other infectious diseases.
 
Market Dynamics
 
Rising prevalence of vaccine-preventable disease in adults leading to increased demand for novel vaccines is driving the market growth. Governmental initiates and free-campaign towards awareness of vaccines among the population is further fueling the market growth. Also, Governmental investment in R&D for the development of vaccines for fatal diseases is boosting the market growth. However, lack of skilled professional and side effects associated with the certain vaccine is expected to hinder the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of adult vaccine.
 
Market Segmentation
 
The broad adult vaccine market has been sub-grouped into type and disease. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

  • Preventive Vaccine
  • Therapeutic Vaccine
 
By Disease
  • Influenza
  • Meningococcal
  • Cervical Cancer
  • Zoster Shingles
  • Pneumococcal
  • Hepatitis, Measles, Mumps, Rubella And Varicella (MMRV)
  • Diphtheria, Tetanus, Pertussis (DTP)
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for adult vaccine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Adult Vaccine Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the adult vaccine market include AstraZeneca Plc., Bharat Biotech, CSL Limited, Dynavax Technologies Corporation, GlaxoSmithKline, ImmunoBiology Ltd., Johnson & Johnson, Medimmune, Merck and Co., Novartis, Pfizer, Sanofi Pasteur and Serum Institute of India. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.


METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Adult Vaccine Market
       2.2. Global Adult Vaccine Market Snapshot
 
3 . ADULT VACCINE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Adult Vaccine Market
       3.3. Market Restraints of Adult Vaccine Market
       3.4. Opportunities of Adult Vaccine Market
       3.5. Trends of Adult Vaccine Market
       3.6. Porter’s Five Force Analysis of Adult Vaccine Market
       3.7. Adult Vaccine Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Disease
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Adult Vaccine Value Chain Analysis
       4.2. Adult Vaccine Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Adult Vaccine Raw Material Manufactures List
           4.2.3. Price Trend of Adult Vaccine Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL ADULT VACCINE MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Adult Vaccine Market Analysis by Type
       5.3 Market Analysis of Preventive Vaccine by Regions
       5.4 Market Analysis of Therapeutic Vaccine by Regions
 
6 . GLOBAL ADULT VACCINE MARKET ANALYSIS BY DISEASE
       6.1 Overview by Disease
       6.2 Global Adult Vaccine Market Analysis by Disease
       6.3 Market Analysis of Influenza by Regions
       6.4 Market Analysis of Meningococcal by Regions
       6.5 Market Analysis of Cervical Cancer by Regions
       6.6 Market Analysis of Zoster Shingles by Regions
       6.7 Market Analysis of Pneumococcal by Regions
       6.8 Market Analysis of Hepatitis, Measles, Mumps, Rubella And Varicella (MMRV) by Regions
       6.9 Market Analysis of Diphtheria, Tetanus, Pertussis (DTP) by Regions
 
7 . GLOBAL ADULT VACCINE MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Adult Vaccine Market Estimate by Market Segment
           7.3.3. North America Adult Vaccine Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Adult Vaccine Market Estimate by Market Segment
           7.4.3. Europe Adult Vaccine Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Adult Vaccine Market Estimate by Market Segment
           7.5.3. Asia Pacific Adult Vaccine Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Adult Vaccine Market Estimate by Market Segment
           7.6.3. Latin America Adult Vaccine Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Adult Vaccine Market Estimate by Market Segment
           7.7.3. Middle East & Africa Adult Vaccine Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE ADULT VACCINE COMPANIES
       8.1. Adult Vaccine Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF ADULT VACCINE INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. AstraZeneca Plc.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Bharat Biotech
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. CSL Limited
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Dynavax Technologies Corporation
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. GlaxoSmithKline
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. ImmunoBiology Ltd.
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Johnson & Johnson
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Medimmune
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Merck and Co
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Novartis
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
       9.13. Pfizer
           9.13.1. Company Overview
           9.13.2. Financials
           9.13.3. Products
           9.13.4. Recent Developments
       9.14. Sanofi Pasteur
           9.14.1. Company Overview
           9.14.2. Financials
           9.14.3. Products
           9.14.4. Recent Developments
       9.15. Serum Institute of India
           9.15.1. Company Overview
           9.15.2. Financials
           9.15.3. Products
           9.15.4. Recent Developments
 
10.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       10.1. Impact Analysis of Covid-19 Outbreak on the Market
           10.1.1. Direct Impact on Production
           10.1.2. Supply Chain and Market Disruption
           10.1.3. Financial Impact on Firms and Financial Markets
       10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       10.3. Pre V/S Post COVID-19 Market
       10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       10.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  •  Global Market Snapshot
  •  Drivers of the Global Market Impact Analysis
  •  Restraints of the Global Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers 
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19 Market
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  •  COVID-19: Micro and Macro Factor Analysis on the Market
  •  Global Adult Vaccine Market Analysis by Type (USD MN)
  •  Global Adult Vaccine Market Analysis in Preventive Vaccine by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Therapeutic Vaccine by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis by Disease (USD MN)
  •  Global Adult Vaccine Market Analysis in Influenza by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Meningococcal by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Cervical Cancer by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Zoster Shingles by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Pneumococcal by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Hepatitis, Measles, Mumps, Rubella And Varicella (MMRV) by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Diphtheria, Tetanus, Pertussis (DTP) by Geography (USD MN)
  •  Global Adult Vaccine Market by Geography (USD MN)
  •  North America Adult Vaccine Market Analysis by Type (USD MN)
  •  North America Adult Vaccine Market Estimate by Disease (USD MN)
  •  North America Adult Vaccine Market Estimate by Country (USD MN)
  •  United State Adult Vaccine Market Analysis by Type (USD MN)
  •  United State Adult Vaccine Market Estimate by Disease (USD MN)
  •  Rest of North America Adult Vaccine Market Analysis by Type (USD MN)
  •  Rest of North America Adult Vaccine Market Estimate by Disease (USD MN)
  •  Europe Adult Vaccine Market Analysis by Type (USD MN)
  •  Europe Adult Vaccine Market Estimate by Disease (USD MN)
  •  United Kingdom Adult Vaccine Market Analysis by Type (USD MN)
  •  United Kingdom Adult Vaccine Market Estimate by Disease (USD MN)
  •  France Adult Vaccine Market Analysis by Type (USD MN)
  •  France Adult Vaccine Market Estimate by Disease (USD MN)
  •  Germany Adult Vaccine Market Analysis by Type (USD MN)
  •  Germany Adult Vaccine Market Estimate by Disease (USD MN)
  •  Rest of Europe Adult Vaccine Market Analysis by Type (USD MN)
  •  Rest of Europe Adult Vaccine Market Estimate by Disease (USD MN)
  •  Asia Pacific Adult Vaccine Market Analysis by Type (USD MN)
  •  Asia Pacific Adult Vaccine Market Estimate by Disease (USD MN)
  •  Asia Pacific Adult Vaccine Market Estimate by Country (USD MN)
  •  China Adult Vaccine Market Analysis by Type (USD MN)
  •  China Adult Vaccine Market Estimate by Disease (USD MN)
  •  Japan Adult Vaccine Market Analysis by Type (USD MN)
  •  Japan Adult Vaccine Market Estimate by Disease (USD MN)
  •  India Adult Vaccine Market Analysis by Type (USD MN)
  •  India Adult Vaccine Market Estimate by Disease (USD MN)
  •  Rest of Asia Pacific Adult Vaccine Market Analysis by Type (USD MN)
  •  Rest of Asia Pacific Adult Vaccine Market Estimate by Disease (USD MN)
  •  Latin America Adult Vaccine Market Analysis by Type (USD MN)
  •  Latin America Adult Vaccine Market Estimate by Disease (USD MN)
  •  Latin America Adult Vaccine Market Estimate by Country (USD MN)
  •  Brazil Adult Vaccine Market Analysis by Type (USD MN)
  •  Brazil Adult Vaccine Market Estimate by Disease (USD MN)
  •  Rest of Latin America Adult Vaccine Market Analysis by Type (USD MN)
  •  Rest of Latin America Adult Vaccine Market Estimate by Disease (USD MN)
  •  Middle East & Africa Adult Vaccine Market Analysis by Type (USD MN)
  •  Middle East & Africa Adult Vaccine Market Estimate by Disease (USD MN)
  •  Middle East & Africa Adult Vaccine Market Estimate by Country (USD MN)
  •  Middle East Adult Vaccine Market Analysis by Type (USD MN)
  •  Middle East Adult Vaccine Market Estimate by Disease (USD MN)
  •  Africa Adult Vaccine Market Analysis by Type (USD MN)
  •  Africa Adult Vaccine Market Estimate by Disease (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
 
  •  Research Scope of Adult Vaccine Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Adult Vaccine Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Disease
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Adult Vaccine Market Analysis by Type (USD MN)
  •  Global Adult Vaccine Market Analysis in Preventive Vaccine by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Therapeutic Vaccine by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis by Disease (USD MN)
  •  Global Adult Vaccine Market Analysis in Influenza by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Meningococcal by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Cervical Cancer by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Zoster Shingles by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Pneumococcal by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Hepatitis, Measles, Mumps, Rubella And Varicella (MMRV) by Geography (USD MN)
  •  Global Adult Vaccine Market Analysis in Diphtheria, Tetanus, Pertussis (DTP) by Geography (USD MN)
  •  Latin America Adult Vaccine Market by Revenue
  •  Middle East & Africa Adult Vaccine Market by Revenue
  •  Recent Development in Adult Vaccine Industry
  •  Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials